Wei Zhang

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment

Kathryn M. Connor, Jonathan Davidson, Richard H. Weisler et al. · Psychopharmacology · 2005 · 82 citations

Medicine, Pharmacology, Pharmacotherapy +7

Safety and Pharmacokinetics of CXCR4 Peptide Antagonist, LY2510924, in Combination with Durvalumab in Advanced Refractory Solid Tumors

Mark H. O’Hara, Wells A. Messersmith, Hedy L. Kindler et al. · Journal of Pancreatic Cancer · 2020 · 49 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Addition of Celebrex and Pregabalin to Ropivacaine for Posterior Spinal Surgery: A Randomized, Double-Blinded, Placebo-Controlled Trial

Ye Zhang, Bin He, Jinqiu Zhao et al. · Drug Design Development and Therapy · 2021 · 22 citations · Full text

Medicine, Anesthesiology, Surgery +17